Xia, Li
Tian, Enming
Yu, Mingcheng
Liu, Chenglong
Shen, Lian
Huang, Yafei
Wu, Zhongen
Tian, Jinlong
Yu, Ker
Wang, Yonghui
Xie, Qiong
Article History
Received: 1 November 2021
Accepted: 15 February 2022
First Online: 23 April 2022
Declarations
:
: The institutional review board approved the animal study of the School of Pharmacy, Fudan University (Approval number: 2020–04-YL-ZD-02). Human PBMCs were donated by Li Xia, who provided her written informed consent. The collection of human PBMCs was approved by the ethics committee of the Fudan Affiliated Minhang hospital (2019-Pijian-010-01 K).All animal experiments were approved by the Animal Care and Use Committee at Fudan University and complied with the National Institute of Health Guide for the Care and Use of Laboratory Animals. The approval number is 2020–06-YL-ZD-01, adhering to the ARRIVE guidelines.
: Not applicable
: The authors declare no competing interests.